Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

N/ACompletedNCT02196948

Universidad Rey Juan Carlos36 enrolled

Overview

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Supraspinatus Tendinopathy

Interventions

Electrolysis Percutaneous Therapeutic (EPTE)OTHER

Eccentric exerciseOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Unilateral supraspinatus tendinopathy * Shoulder pain from at least 3 months * Shoulder pain of more than 4 points on a NPRS * Positive findings of supraspinatus tendinopathy on MRI Exclusion Criteria: * bilateral shoulder symptoms * younger than 18 or older than 65 years * history of shoulder fractures or dislocation * cervical radiculopathy * previous interventions with steroid injections * fibromyalgia syndrome * previous history of shoulder or neck surgery * any type of intervention for the neck-shoulder area during the previous year

Locations (1)

Universidad Rey Juan Carlos

Alcorcón, Madrid, Spain

Outcomes

Primary Outcomes

Changes in pain intensity before and after the intervention

A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of shoulder pain, and the worst and lowest level of pain experienced in the preceding week in the shoulder area.

Time frame: Baseline, after 2 weeks of treatment and one week after the last session

Secondary Outcomes

Changes in disability before and after the intervention

The Disabilities of the Arm, Shoulder and Hand (DASH) will be used to determine the disability induced by shoulder pain

Time frame: Baseline, after 2 weeks of treatment and one week after the last session

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.